HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kari Syrjänen Selected Research

gastrin 17 (G 17)

11/2021Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel® Test.
2/2017Slow-release L-cysteine capsule prevents gastric mucosa exposure to carcinogenic acetaldehyde: results of a randomised single-blinded, cross-over study of Helicobacter-associated atrophic gastritis.
8/2016Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
10/2013Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kari Syrjänen Research Topics

Disease

18Colorectal Neoplasms (Colorectal Cancer)
04/2019 - 04/2007
17Neoplasms (Cancer)
11/2021 - 08/2008
16Papillomavirus Infections
01/2022 - 10/2005
13Infections
01/2022 - 09/2006
12Uterine Cervical Dysplasia
07/2010 - 12/2004
11Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2012 - 12/2004
8Atrophic Gastritis
04/2022 - 10/2013
7Disease Progression
12/2017 - 11/2008
6Carcinoma (Carcinomatosis)
04/2018 - 01/2008
6Neoplasm Metastasis (Metastasis)
12/2017 - 04/2007
5Carcinogenesis
08/2021 - 07/2005
5Rectal Neoplasms (Rectal Cancer)
01/2018 - 03/2011
4Stomach Neoplasms (Stomach Cancer)
11/2021 - 01/2016
4Abdominal Pain (Pain, Abdominal)
09/2021 - 03/2021
3Adenoma (Adenomas)
01/2022 - 11/2008
3Squamous Cell Carcinoma of Head and Neck
04/2018 - 02/2012
3Adenocarcinoma
01/2018 - 07/2009
3Melanoma (Melanoma, Malignant)
02/2015 - 08/2008
2Polyps
01/2022 - 12/2010
2Breast Neoplasms (Breast Cancer)
03/2020 - 08/2012
2Microsatellite Instability
11/2018 - 11/2008
2Tobacco Use Disorder (Nicotine Dependence)
01/2017 - 05/2016
2Hypoxia (Hypoxemia)
08/2012 - 12/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2009 - 07/2005
2Squamous Intraepithelial Lesions
09/2007 - 07/2006
1Atrophy
03/2022
1Dyspepsia (Indigestion)
09/2021
1Renal Colic
06/2021
1Peptic Ulcer (Peptic Ulcers)
03/2019
1Hemorrhage
03/2019
1Lymphoma (Lymphomas)
03/2019
1Esophagitis
01/2018
1Colonic Neoplasms (Colon Cancer)
12/2017
1Coinfection
02/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2012

Drug/Important Bio-Agent (IBA)

17Biomarkers (Surrogate Marker)IBA
04/2022 - 04/2008
7Proteins (Proteins, Gene)FDA Link
11/2018 - 11/2006
7DNA (Deoxyribonucleic Acid)IBA
04/2018 - 09/2006
6AntibodiesIBA
01/2022 - 11/2006
4gastrin 17 (G 17)IBA
11/2021 - 10/2013
4antiarrhythmic peptide (AAP)IBA
09/2021 - 03/2021
4Cadherins (E-Cadherin)IBA
04/2019 - 04/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2019 - 04/2008
4Messenger RNA (mRNA)IBA
12/2015 - 08/2010
4ezrinIBA
08/2012 - 12/2008
3ParaffinIBA
01/2022 - 10/2005
3Immunoglobulin G (IgG)IBA
11/2021 - 10/2013
3Cysteine (L-Cysteine)FDA Link
02/2017 - 05/2016
3Pepsinogen A (Pepsinogen)IBA
02/2017 - 10/2013
3AcetaldehydeIBA
02/2017 - 05/2016
3RNA (Ribonucleic Acid)IBA
01/2017 - 08/2011
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2013 - 07/2009
2CytokinesIBA
10/2021 - 12/2009
2HLA-G Antigens (HLA G)IBA
05/2021 - 06/2018
2Irinotecan (Camptosar)FDA LinkGeneric
04/2019 - 11/2018
2Fluorouracil (Carac)FDA LinkGeneric
11/2018 - 11/2008
2Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
01/2018 - 12/2015
2Calcibiotic Root Canal SealerIBA
04/2013 - 11/2008
2Glucose (Dextrose)FDA LinkGeneric
08/2012 - 12/2011
2Carbonic Anhydrase IXIBA
08/2012 - 12/2011
2Progesterone Receptors (Progesterone Receptor)IBA
08/2012 - 09/2011
2Oral ContraceptivesIBA
01/2012 - 11/2006
2Cyclin-Dependent Kinase Inhibitor p16IBA
09/2011 - 09/2007
2Telomerase (Telomerase Reverse Transcriptase)IBA
08/2010 - 04/2008
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2010 - 01/2009
2Matrix Metalloproteinases (MMPs)IBA
01/2010 - 08/2008
2VaccinesIBA
07/2009 - 11/2006
2Biological ProductsIBA
01/2009 - 12/2008
2Thymidylate SynthaseIBA
12/2008 - 04/2007
2Laminin ReceptorsIBA
04/2008 - 01/2006
2SurvivinIBA
04/2008 - 07/2005
1Formaldehyde (Formol)FDA Link
01/2022
1Hemoglobins (Hemoglobin)IBA
11/2021
1HaptoglobinsIBA
11/2021
1InterferonsIBA
10/2021
1Interleukin-5 (Interleukin 5)IBA
10/2021
1artemisinin-naphthoquine combinationIBA
06/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
05/2021
1Insulin-Like PeptidesIBA
03/2020
1Anti-Bacterial Agents (Antibiotics)IBA
03/2019
1Proton Pump InhibitorsIBA
03/2019
1GuaiacIBA
01/2019
1Leucovorin (Folinic Acid)FDA Link
11/2018
1Viral DNAIBA
04/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1Capsules (Microcapsules)IBA
02/2017
1Neurofibromin 1 (Neurofibromin)IBA
10/2016
1protein phosphatase methylesterase-1IBA
12/2015
1Interferon alpha-2 (Roferon-A)FDA Link
02/2015
1Estrogens (Estrogen)FDA Link
08/2012
1Estrogen ReceptorsIBA
08/2012
1Papillomavirus Vaccines (HPV Vaccines)IBA
07/2012
1Epidermal Growth Factor (EGF)IBA
01/2012
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
10/2011
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2011
1Bevacizumab (Avastin)FDA Link
10/2011
1retinoic acid receptor betaIBA
09/2011

Therapy/Procedure

6Therapeutics
01/2018 - 11/2008
5Radiotherapy
01/2018 - 03/2011
1Drug Therapy (Chemotherapy)
12/2017